Nathan Bittner

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA 98195 6043, USA
    Am J Clin Oncol 31:231-6. 2008
  2. ncbi Primary causes of death after permanent prostate brachytherapy
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA 26003 6300, USA
    Int J Radiat Oncol Biol Phys 72:433-40. 2008
  3. ncbi Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, Washington, USA
    Urology 74:171-6. 2009
  4. ncbi Role of trospium chloride in brachytherapy-related detrusor overactivity
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, Washington, USA
    Urology 71:460-4. 2008
  5. ncbi Erectile dysfunction is predictive of all-cause mortality in patients with prostate cancer treated with permanent interstitial brachytherapy
    Nathan Bittner
    Tacoma Valley Radiation Oncology Centers, Tacoma, WA, USA
    BJU Int 109:220-5. 2012
  6. ncbi Treatment of locally advanced adenoid cystic carcinoma of the trachea with neutron radiotherapy
    Nathan Bittner
    Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA 98195, USA
    Int J Radiat Oncol Biol Phys 72:410-4. 2008
  7. ncbi The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapy
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    Brachytherapy 6:258-66. 2007
  8. ncbi Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy
    Christopher R Loiselle
    Department of Radiation Oncology, University of Washington Medical Center, Seattle, Washington 98195, USA
    Int J Radiat Oncol Biol Phys 76:1314-9. 2010

Detail Information

Publications8

  1. ncbi The time gap between Pd-103 prostate brachytherapy and supplemental beam radiation does not impact on rectal morbidity or likelihood of cure
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA 98195 6043, USA
    Am J Clin Oncol 31:231-6. 2008
    ..To determine whether treatment gap between supplemental beam radiation and brachytherapy implant affects rectal morbidity and likelihood of cure in the treatment of intermediate-risk prostate cancer...
  2. ncbi Primary causes of death after permanent prostate brachytherapy
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA 26003 6300, USA
    Int J Radiat Oncol Biol Phys 72:433-40. 2008
    ..To evaluate the primary causes of death in low-risk (low-risk), intermediate-risk (intermediate-risk), and high-risk (high-risk) patients undergoing permanent prostate brachytherapy with or without supplemental therapies...
  3. ncbi Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, Washington, USA
    Urology 74:171-6. 2009
    ..PSAV has been associated with greater Gleason scores and greater prostate cancer-specific mortality...
  4. ncbi Role of trospium chloride in brachytherapy-related detrusor overactivity
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, Washington, USA
    Urology 71:460-4. 2008
    ..In this study, we evaluated the impact of trospium chloride in prostate brachytherapy patients with symptoms consistent with an overactive bladder (OAB)...
  5. ncbi Erectile dysfunction is predictive of all-cause mortality in patients with prostate cancer treated with permanent interstitial brachytherapy
    Nathan Bittner
    Tacoma Valley Radiation Oncology Centers, Tacoma, WA, USA
    BJU Int 109:220-5. 2012
    ..To evaluate the relationship between pre-treatment erectile function and all-cause mortality in patients with prostate cancer treated with brachytherapy...
  6. ncbi Treatment of locally advanced adenoid cystic carcinoma of the trachea with neutron radiotherapy
    Nathan Bittner
    Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA 98195, USA
    Int J Radiat Oncol Biol Phys 72:410-4. 2008
    ..To examine the efficacy of fast neutron radiotherapy in the treatment of locally advanced adenoid cystic carcinoma (ACC) of the trachea and to compare outcomes with and without high-dose-rate (HDR) endobronchial brachytherapy boost...
  7. ncbi The impact of acute urinary morbidity on late urinary function after permanent prostate brachytherapy
    Nathan Bittner
    Department of Radiation Oncology, University of Washington, Seattle, WA, USA
    Brachytherapy 6:258-66. 2007
    ..Acute prostate brachytherapy-related morbidity is dominated by urinary symptomatology. In this study, we evaluated the effect of severe early brachytherapy-related urinary morbidity on late urinary function...
  8. ncbi Dynamic contrast-enhanced MRI kinetics of invasive breast cancer: a potential prognostic marker for radiation therapy
    Christopher R Loiselle
    Department of Radiation Oncology, University of Washington Medical Center, Seattle, Washington 98195, USA
    Int J Radiat Oncol Biol Phys 76:1314-9. 2010
    ..Our goal was to determine the correlations between dynamic contrast-enhanced MRI (DCE-MRI) kinetics of breast cancers and axillary nodal status (ANS) which may have prognostic value in designing radiation therapy recommendations...